FBRX
Forte Biosciences, Inc.
NASDAQ · Healthcare · Biotechnology · US
$76.99
+0.00%Next report
Analyst consensus
- Next report date
- Nov 13, 2026
- EPS estimate
- -$0.90
- Revenue estimate
- —
Latest reported
- Last report date
- Aug 11, 2026
- EPS actual
- -$0.97
- EPS estimate
- -$0.99
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 6
- EPS misses (12Q)
- 5
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -0.4%
- Revenue beats (12Q)
- —
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 11, 2026 | -$0.99 | -$0.97 | Beat 2.51% | — |
| May 11, 2026 | -$1.16 | -$1.24 | Miss -6.90% | — |
| Mar 31, 2026 | -$1.42 | -$1.45 | Miss -2.11% | — |
| Nov 14, 2025 | -$1.04 | -$0.99 | Beat 4.81% | — |
| Aug 14, 2025 | -$1.21 | -$0.96 | Beat 20.66% | — |
| May 15, 2025 | -$0.89 | -$1.37 | Miss -53.93% | — |
| Mar 24, 2025 | -$4.55 | -$2.45 | Beat 46.15% | — |
| Nov 14, 2024 | -$6.75 | -$4.54 | Beat 32.74% | — |
| Aug 14, 2024 | -$4.00 | -$6.75 | Miss -68.75% | — |
| Mar 18, 2024 | -$0.28 | -$1.00 | Miss -257.14% | $6.0K |
| Nov 13, 2023 | -$14 | -$6.50 | Beat 54.39% | — |
| Aug 14, 2023 | — | -$11 | — | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 13, 2026